Skip to main content
Article
Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in FCS in mice and humans
Blood (2007)
  • Norihisa Sakamoto, Food and Drug Administration
  • Kazuhide Tsuji, Center for Drug Evaluation and Research
  • Linda M. Muul, National Institutes of Health
  • Ann M. Lawler
  • Fabiana Emanuel
  • Fabio Candotti, National Institutes of Health
  • Julia A. Metcalf, National Institutes of Health
  • Jorge A. Tavel, National Institutes of Health
  • Walter J. Urba, Providence Portland Medical Center
  • Bernard A. Fox, Providence Portland Medical Center
  • Ajit Varki, University of California, San Diego
  • Joan K. Lunney, United States Department of Agriculture
  • Amy S. Rosenberg, Food and Drug Administration
  • Robert W. Franz
Disciplines
Publication Date
March 29, 2007
DOI
10.1182/blood-2007-01-066522
Citation Information
Norihisa Sakamoto, Kazuhide Tsuji, Linda M. Muul, Ann M. Lawler, et al.. "Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in FCS in mice and humans" Blood (2007) ISSN: 1528-0020
Available at: http://works.bepress.com/walter-urba/196/